Agency, New Delhi
Published by: Kuldeep Singh |
Updated to Tuesday, 26 October 2021 03:10 AM IST
Kovacin, India’s first indigenous vaccine, can be approved internationally today. The decision could be taken at today’s World Health Organization (WHO) meeting.
Listen to the news
The decision will be taken at the World Health Organization meeting today
WHO Chief Scientist Dr Soumya Swaminathan said last week that the meeting on October 26 would decide on the inclusion of Kovacin Vaccine of India Biotech in the world-class emergency use list.
The WHO said Bharat Biotech had provided all the documents related to Kovacsin, the review of which was almost complete. At Tuesday’s meeting, the committee’s experts will not only express their views, but also consider the vaccine’s effectiveness, safety and antibody level, based on which Kovacsin can be added to the list. Emergency use.
Covaxin is not yet internationally approved, making Covaxin supplements not eligible for overseas travel. In most countries, only people who have received a dose of the vaccine listed internationally are included.